Wassim Fares
Keine laufenden Positionen mehr
Profil
Wassim Fares worked as a Senior Medical Director at Janssen Pharmaceuticals, Inc. and as a Chief Medical Officer at Bellerophon Therapeutics, Inc. He received a graduate degree from The University of North Carolina at Chapel Hill and undergraduate and doctorate degrees from the American University of Beirut.
Ehemalige bekannte Positionen von Wassim Fares
| Unternehmen | Position | Ende |
|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Wassim Fares
| American University of Beirut | Doctorate Degree |
| The University of North Carolina at Chapel Hill | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
